Healthcare Triangle, Inc. logo

Healthcare Triangle, Inc.

HCTI

NASDAQHealthcareMedical - Healthcare Information Services

Previous close

$0.8787

−$0.0612 · -6.51%

Aug 21, 4:00 PM ET

HCTI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

61

Undervalued

Momentum

19

Strong Down

Sentiment

51

Mixed

Risk resilience

28

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and streamline digital transformation. Among its proprietary software offerings are CloudEz, an enterprise platform streamlining multi-cloud migration and oversight, allowing clients to unify management of their private, hybrid, and public cloud environments. Another key platform is DataEz, a cloud-native solution providing robust data analytics and scientific data processing capabilities tailored for the life sciences, pharmaceutical, and healthcare provider sectors. Additionally, the company offers Readabl.AI, a Software-as-a-Service (SaaS) solution leveraging public cloud-based artificial intelligence and machine learning to intelligently identify and extract vital healthcare data from diverse documents such as faxes and narrative reports. Beyond its platforms, Healthcare Triangle delivers a range of cloud-centric IT services and specialized healthcare IT support. This includes the implementation, optimization, and integration of electronic health records (EHR) systems with community partners, comprehensive application managed services, and reliable public cloud-based backup and disaster recovery solutions. Its diverse client base spans healthcare providers, insurance carriers, pharmaceutical and life sciences firms, biotechnology companies, and medical device manufacturers. Established in 2019, Healthcare Triangle, Inc. operates out of Pleasanton, California, as a subsidiary of SecureKloud Technologies, Inc.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Lakshmanan Kannappan
Listed since
Oct 13, 2021
Employees
41

Market position

Day range

Current $0.8787

52-week range

Current $0.8787

Open
$0.9721
Previous close
$0.9399
Volume
279.02K
0.37× average
Average volume
749.94K
Average daily volume
Market cap
1.02M USD
Beta
1.12
Market reference 1
50-day average
$1.6516
-46.80% below average
200-day average
$29.2042
-96.99% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
3.14M USD
P/E (TTM)
-0×
P/B (TTM)
0.05×
P/S (TTM)
0.04×
EV / EBITDA
-0.38×
Earnings yield
-40338.77%
Free cash flow yield
-70337.43%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
18.37%
Operating margin
-57.35%
Net margin
-66.29%
Return on equity
-94.94%
Return on assets
-41.68%
Return on invested capital
-47.33%

Financial health

Debt / equity
0.26×
Current ratio
1.03×
Altman Z-score
-1.49
Piotroski F-score
2 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends40%-0%-40%-81%Gross margin, FY2021: 29.83%Gross margin, FY2022: 24.62%Gross margin, FY2023: 20.41%Gross margin, FY2024: 24.71%Gross margin, FY2025: 13.61%Operating margin, FY2021: -15.19%Operating margin, FY2022: -35.57%Operating margin, FY2023: -23.18%Operating margin, FY2024: -40.62%Operating margin, FY2025: -70.47%Net margin, FY2021: -16.87%Net margin, FY2022: -31.29%Net margin, FY2023: -26.16%Net margin, FY2024: -51.03%Net margin, FY2025: -68.22%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 29.83%. Gross margin FY2022 24.62%. Gross margin FY2023 20.41%. Gross margin FY2024 24.71%. Gross margin FY2025 13.61%. Operating margin FY2021 -15.19%. Operating margin FY2022 -35.57%. Operating margin FY2023 -23.18%. Operating margin FY2024 -40.62%. Operating margin FY2025 -70.47%. Net margin FY2021 -16.87%. Net margin FY2022 -31.29%. Net margin FY2023 -26.16%. Net margin FY2024 -51.03%. Net margin FY2025 -68.22%.

Income trends

Revenue

13.89M USD+18.77%

Operating income

−9.79M USD-106.04%

Net income

−9.48M USD-58.75%
Income trends across reported periods52.11M USD27.22M USD2.34M USD−22.54M USDRevenue, FY2021: 35.27M USDRevenue, FY2022: 45.89M USDRevenue, FY2023: 33.2M USDRevenue, FY2024: 11.7M USDRevenue, FY2025: 13.89M USDOperating income, FY2021: −5.36M USDOperating income, FY2022: −16.32M USDOperating income, FY2023: −7.7M USDOperating income, FY2024: −4.75M USDOperating income, FY2025: −9.79M USDNet income, FY2021: −5.95M USDNet income, FY2022: −14.36M USDNet income, FY2023: −8.69M USDNet income, FY2024: −5.97M USDNet income, FY2025: −9.48M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 35.27M USD. Revenue FY2022 45.89M USD. Revenue FY2023 33.2M USD. Revenue FY2024 11.7M USD. Revenue FY2025 13.89M USD. Operating income FY2021 −5.36M USD. Operating income FY2022 −16.32M USD. Operating income FY2023 −7.7M USD. Operating income FY2024 −4.75M USD. Operating income FY2025 −9.79M USD. Net income FY2021 −5.95M USD. Net income FY2022 −14.36M USD. Net income FY2023 −8.69M USD. Net income FY2024 −5.97M USD. Net income FY2025 −9.48M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue13.89M USD11.7M USD33.2M USD45.89M USD35.27M USD
Cost of goods sold12M USD8.81M USD26.43M USD34.59M USD24.75M USD
Gross profit1.89M USD2.89M USD6.78M USD11.3M USD10.52M USD
Research and development536K USD429K USD799K USD8.14M USD5.26M USD
Selling, general, and administrative10.42M USD6.15M USD10.4M USD12.17M USD9.2M USD
Operating expenses11.68M USD7.64M USD14.47M USD27.62M USD15.88M USD
Interest expense567K USD1.21M USD968K USD212K USD567K USD
Depreciation and amortization705K USD889K USD1.57M USD2.94M USD1.42M USD
Operating income−9.79M USD−4.75M USD−7.7M USD−16.32M USD−5.36M USD
Net income−9.48M USD−5.97M USD−8.69M USD−14.36M USD−5.95M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
73%
8 beats, 2 misses, 1 met estimate
Average EPS surprise
-20.66%
11 comparable reports
Latest EPS result
-1.56
Estimate -3.43 · Beat by 54.52%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.06-1,613.56-3,227.06-4,840.55Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ2 '26BeatQ2 '26MetQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 31, 2025: actual -34.43, estimate -59.76, surprise +42.38%, Beat. Q2 2025, reported May 20, 2025: actual -25.45, estimate -44.82, surprise +43.22%, Beat. Q3 2025, reported Aug 14, 2025: actual -34.73, estimate -4,482, surprise +99.23%, Beat. Q4 2025, reported Nov 13, 2025: actual -25.15, estimate -13.17, surprise -90.96%, Miss. Q2 2026, reported Apr 15, 2026: actual -0.07, estimate -0.2, surprise +65.00%, Beat. Q2 2026, reported May 19, 2026: actual -6.84, estimate -6.84, surprise 0.00%, Met estimate. Q3 2026, reported Aug 13, 2026: actual -1.56, estimate -3.43, surprise +54.52%, Beat. Q4 2026, reported Nov 12, 2026: actual —, estimate -0.97, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates15.81M11.16M6.51M1.86MQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ2 '26MissQ2 '26MetQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 31, 2025: actual 2.19M USD, estimate 12.9M USD, surprise -83.02%, Miss. Q2 2025, reported May 20, 2025: actual 3.7M USD, estimate 13.6M USD, surprise -72.76%, Miss. Q3 2025, reported Aug 14, 2025: actual 3.56M USD, estimate 14.5M USD, surprise -75.46%, Miss. Q4 2025, reported Nov 13, 2025: actual 3.49M USD, estimate 14.8M USD, surprise -76.43%, Miss. Q2 2026, reported Apr 15, 2026: actual 3.14M USD, estimate 6.11M USD, surprise -48.61%, Miss. Q2 2026, reported May 19, 2026: actual 9.86M USD, estimate 9.86M USD, surprise 0.00%, Met estimate. Q3 2026, reported Aug 13, 2026: actual 9.19M USD, estimate 10.35M USD, surprise -11.16%, Miss. Q4 2026, reported Nov 12, 2026: actual —, estimate 9.65M USD, surprise —, Comparison unavailable.

HCTI news

HCTI peers

ETFs holding HCTI

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research HCTI

research.disclaimer